Chemical Component Summary

Nameavacopan
Identifiers(2~{R},3~{S})-2-[4-(cyclopentylamino)phenyl]-1-(2-fluoranyl-6-methyl-phenyl)carbonyl-~{N}-[4-methyl-3-(trifluoromethyl)phenyl]piperidine-3-carboxamide
FormulaC33 H35 F4 N3 O2
Molecular Weight581.64
TypeNON-POLYMER
Isomeric SMILESCc1ccc(NC(=O)[C@H]2CCCN([C@H]2c3ccc(NC4CCCC4)cc3)C(=O)c5c(C)cccc5F)cc1C(F)(F)F
InChIInChI=1S/C33H35F4N3O2/c1-20-12-15-25(19-27(20)33(35,36)37)39-31(41)26-10-6-18-40(32(42)29-21(2)7-5-11-28(29)34)30(26)22-13-16-24(17-14-22)38-23-8-3-4-9-23/h5,7,11-17,19,23,26,30,38H,3-4,6,8-10,18H2,1-2H3,(H,39,41)/t26-,30-/m0/s1
InChIKeyPUKBOVABABRILL-YZNIXAGQSA-N

Chemical Details

Formal Charge0
Atom Count77
Chiral Atom Count2
Bond Count81
Aromatic Bond Count18

Drug Info: DrugBank

DrugBank IDDB15011 
NameAvacopan
Groupsinvestigational
DescriptionAvacopan is under investigation in clinical trial NCT02994927 (A Phase 3 Clinical Trial of CCX168 (Avacopan) in Patients With ANCA-Associated Vasculitis).
SynonymsAvacopan
Categories
  • Amines
  • Piperidines
CAS number1346623-17-3